Clinical Trial Update: Anemia Studies in CKD: Erythropoiesis Via a Novel PHI Daprodustat - Pediatric (ASCEND-P) [Phase 3]

View source ↗

Summary

Phase 3 pediatric trial of daprodustat for anemia in chronic kidney disease has completed; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Anemia of Chronic Kidney Disease

Drugs mentioned

• Daprodustat (daprodustat)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Anaemia | Phase 3 | Status: COMPLETED | Results posted: 2025-11-10